| Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ... Nature 582 (7811), 289-293, 2020 | 3980 | 2020 |
| Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur Z Jin, Y Zhao, Y Sun, B Zhang, H Wang, Y Wu, Y Zhu, C Zhu, T Hu, X Du, ... Nature structural & molecular biology 27 (6), 529-532, 2020 | 396 | 2020 |
| High-throughput screening identifies established drugs as SARS-CoV-2 PLpro inhibitors Y Zhao, X Du, Y Duan, X Pan, Y Sun, T You, L Han, Z Jin, W Shang, J Yu, ... Protein & cell 12 (11), 877-888, 2021 | 105 | 2021 |
| Structural basis for replicase polyprotein cleavage and substrate specificity of main protease from SARS-CoV-2 Y Zhao, Y Zhu, X Liu, Z Jin, Y Duan, Q Zhang, C Wu, L Feng, X Du, J Zhao, ... Proceedings of the National Academy of Sciences 119 (16), e2117142119, 2022 | 92 | 2022 |
| Structure-based drug design, virtual screening and high-throughput screening rapidly identify antiviral leads targeting COVID-19 Z Jin, X Du, Y Xu, Y Deng, M Liu, Y Zhao, B Zhang, X Li, L Zhang, C Peng, ... | 72 | 2020 |
| Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug Z Jin, Y Zhao, Y Sun, B Zhang, H Wang, Y Wu, Y Zhu, C Zhu, T Hu, X Du, ... bioRxiv, 2020.04. 09.033233, 2020 | 6 | 2020 |
| Structural basis for the inhibition of COVID-19 virus main protease by carmofur, an antineoplastic drug (preprint) Z Jin, Y Zhao, Y Sun, B Zhang, H Wang, Y Wu, Y Zhu, C Zhu, T Hu, X Du, ... | | 2020 |
luke guddatThe University of QueenslandVerified email at uq.edu.au
